Basem Goueli is Recognized by Continental Who's
Retrieved on:
Saturday, February 5, 2022
Business administration, Luke the Evangelist, AstraZeneca, Mayo Clinic College of Medicine and Science, Artificial intelligence, UNC, Precision medicine, Oncology, Master of Business Administration, University, Blueprint, Algorithm, Internal medicine, Doctor of Medicine, Research, St Luke's, Clinical trial, The New England Journal of Medicine, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Hospital, National, Empathy, Publication, Regional Cancer Centre, Thiruvananthapuram, Covenant, Stanford University, Continental, Associate, CEO, Health care, Chapel Hill, MIT, Doctorate, Janssen, Doctor of Philosophy, Machine learning, MD, Buffalo, George Washington University, University of North Carolina at Pembroke, MBA, Medicine, Medical device, Lancet, Hematology, Science, Medicine, Genentech, Biochemistry
EAST AMHURST, N.Y., Feb. 4, 2022 /PRNewswire/ -- Basem Goueli, MD, Ph.D., MBA, is being recognized by Continental Who's Who as aDistinguished CEOin the Healthcare field and in acknowledgment of his work at CancerLight, CancerClarity, and Xbiotech.
Key Points:
- EAST AMHURST, N.Y., Feb. 4, 2022 /PRNewswire/ -- Basem Goueli, MD, Ph.D., MBA, is being recognized by Continental Who's Who as aDistinguished CEOin the Healthcare field and in acknowledgment of his work at CancerLight, CancerClarity, and Xbiotech.
- Basem Goueli is a seasoned healthcare professional and executive who recently started two medical businesses, CancerLight and CancerClarity.
- Dr. Goueli completed a Bachelor of Science in Biochemistry/Genetics/Cell Biology at the University of Minnesota in 1996.
- Dr. Goueli did his fellowship in Hematology and Medical Oncology and post-doctoral fellowship in biochemistry at Stanford University from 2008-2012.